2020 | Lewis Antigen Phenotype and Survival of Patients With Pancreatic Cancer | PANCREAS |
2020 | Radiographic portal or superior mesenteric vein invasion is an independent prognostic factor in non-metastatic pancreatic ductal adenocarcinoma: A missing block of clinical T staging? | PANCREATOLOGY |
2020 | Single-center risk factor analysis for FOLFIRINOX associated febrile neutropenia in patients with pancreatic cancer | CANCER CHEMOTHERAPY AND PHARMACOLOGY |
2020 | FOLFIRINOX vs gemcitabine/nab-paclitaxel for treatment of metastatic pancreatic cancer: Single-center cohort study
| WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY |
2020 | Preoperative prediction of futile surgery in patients with radiologically resectable or borderline resectable pancreatic adenocarcinoma | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
2020 | Analysis of Clinical Predictive Factors Affecting the Outcome of Second-Line Chemotherapy for Gemcitabine-Refractory Advanced Pancreatic Cancer
| GUT AND LIVER |
2019 | Skeletal Muscle Mass Predicts Poor Prognosis in Patients with Advanced Pancreatic Cancer Undergoing Second-Line FOLFIRINOX Chemotherapy | NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL |
2019 | A novel lumen-apposing metal stent with an anti-reflux valve for endoscopic ultrasound-guided drainage of pseudocysts and walled-off necrosis: A pilot study
| PLoS One |
2019 | Establishment of pancreatic cancer cell lines with endoscopic ultrasound‐guided biopsy via conditionally reprogrammed cell culture
| CANCER MEDICINE |
2019 | Bleeding Complications and Clinical Safety of Endoscopic Retrograde Cholangiopancreatography in Patients with Liver Cirrhosis
| YONSEI MEDICAL JOURNAL |
2019 | Identification of potential biomarkers for diagnosis of pancreatic and biliary tract cancers by sequencing of serum microRNAs
| BMC MEDICAL GENOMICS |
2019 | Novel Gastric Cancer Stem Cell-Related Marker LINGO2 Is Associated with Cancer Cell Phenotype and Patient Outcome | INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES |
2019 | KML001, an arsenic compound, as salvage chemotherapy in refractory biliary tract cancers: A prospective study | HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL |
2018 | Clinical Value of Contrast-Enhanced Harmonic Endoscopic Ultrasonography in the Differential Diagnosis of Pancreatic and Gallbladder Masses
| CLINICAL ENDOSCOPY |
2018 | Pancreatic-cancer-cell-derived trefoil factor 2 impairs maturation and migration of human monocyte-derived dendritic cells in vitro
| ANIMAL CELLS AND SYSTEMS |
2018 | Comparison of efficacy and safety between standard-dose and modified-dose FOLFIRINOX as a first-line treatment of pancreatic cancer
| WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY |
2018 | 디지털 헬스케어 서비스에 대한 보건의료제공자의 인식
| Journal of Health Informatics and Statistics (보건정보통계학회지) |
2018 | Combined use of CEMIP and CA 19-9 enhances diagnostic accuracy for pancreatic cancer
| SCIENTIFIC REPORTS |
2018 | Urgent endoscopic retrograde cholangiopancreatography is not superior to early ERCP in acute biliary pancreatitis with biliary obstruction without cholangitis
| PLOS ONE |
2017 | Efficacy and treatment-related adverse events of gemcitabine plus nab-paclitaxel for treatment of metastatic pancreatic cancer "in a Korean" population: A single-center cohort study | SEMINARS IN ONCOLOGY |
2017 | Combination Therapy with Capecitabine and Cisplatin as Second-Line Chemotherapy for Advanced Biliary Tract Cancer | CHEMOTHERAPY |
2017 | Suppression of pancreatic adenocarcinoma upregulated factor (PAUF) increases the sensitivity of pancreatic cancer to gemcitabine and 5FU; and inhibits the formation of pancreatic cancer stem like cells
| ONCOTARGET |
2017 | Diagnostic Value of Endoscopic Ultrasonography in Symptomatic Patients with High and Intermediate Probabilities of Common Bile Duct Stones and a Negative Computed Tomography Scan
| GUT AND LIVER |
2017 | Clinical outcomes of everolimus in patients with advanced, nonfunctioning pancreatic neuroendocrine tumors: a multicenter study in Korea | CANCER CHEMOTHERAPY AND PHARMACOLOGY |
2017 | CG200745, an HDAC inhibitor, induces anti-tumour effects in cholangiocarcinoma cell lines via miRNAs targeting the Hippo pathway
| SCIENTIFIC REPORTS |
2017 | Assessment of the Risk of Colorectal Cancer Survivors Developing a Second Primary Pancreatic Cancer
| GUT AND LIVER |
2017 | 디지털 헬스케어 서비스에 대한 일반인의 인식
| Journal of Digital Contents Society (디지털콘텐츠학회논문지) |
2017 | The Significance of the Prognostic Nutritional Index for All Stages of Pancreatic Cancer | NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL |
2017 | A prospective randomized study for efficacy of an uncovered double bare metal stent compared to a single bare metal stent in malignant biliary obstruction | SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES |
2017 | Clinical characteristics of second primary pancreatic cancer
| PLOS ONE |
2017 | Sorafenib inhibits 5-fluorouracil-resistant gastric cancer cell growth. | SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY |
2017 | Best options for preoperative biliary drainage in patients with Klatskin tumors | SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES |
2017 | The DNA aptamer binds stemness-enriched cancer cells in pancreatic cancer | JOURNAL OF MOLECULAR RECOGNITION |
2017 | A novel HDAC inhibitor, CG200745, inhibits pancreatic cancer cell growth and overcomes gemcitabine resistance
| SCIENTIFIC REPORTS |
2017 | Benefit of neoadjuvant concurrent chemoradiotherapy for locally advanced perihilar cholangiocarcinoma
| WORLD JOURNAL OF GASTROENTEROLOGY |
2017 | A randomized, multicenter, phase III study of gemcitabine combined with capecitabine versus gemcitabine alone as first-line chemotherapy for advanced pancreatic cancer in South Korea.
| MEDICINE |
2016 | Concomitant Statin Use Has a Favorable Effect on Gemcitabine-Erlotinib Combination Chemotherapy for Advanced Pancreatic Cancer
| YONSEI MEDICAL JOURNAL |
2016 | Visceral Obesity is Associated with Poor Prognosis in Pancreatic Adenocarcinoma | NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL |
2016 | Prognostic Validity of the American Joint Committee on Cancer and the European Neuroendocrine Tumors Staging Classifications for Pancreatic Neuroendocrine Tumors: A Retrospective Nationwide Multicenter Study in South Korea | PANCREAS |
2016 | Immunotherapy in Pancreatic Cancer; the Road Less Traveled
| Immunological Disorders & Immunotherapy |
2016 | A pilot study of concurrent chemoradiotherapy with gemcitabine and cisplatin in patients with locally advanced biliary tract cancer | CANCER CHEMOTHERAPY AND PHARMACOLOGY |
2016 | Risk Factors Associated with Loco-Regional Failure after Surgical Resection in Patients with Resectable Pancreatic Cancer.
| PLOS ONE |
2016 | Embigin is overexpressed in pancreatic ductal adenocarcinoma and regulates cell motility through epithelial to mesenchymal transition via the TGF-β pathway. | MOLECULAR CARCINOGENESIS |
2016 | Prospective Study for Comparison of Endoscopic Ultrasound-Guided Tissue Acquisition Using 25- and 22-Gauge Core Biopsy Needles in Solid Pancreatic Masses
| PLOS ONE |
2016 | Statin Use and Its Impact on Survival in Pancreatic Cancer Patients Cancer Patients
| MEDICINE |
2016 | Can metformin change the prognosis of pancreatic cancer? Retrospective study for pancreatic cancer patients with pre-existingdiabetes existingdiabetes mellitus type 2 | DIGESTIVE AND LIVER DISEASE |
2016 | A Comparison of Gastrointestinal Toxicities between Intensity-Modulated Radiotherapy and Three-Dimensional Conformal Radiotherapy for Pancreatic Cancer.
| GUT AND LIVER |
2016 | Cholecystectomy for Prevention of Recurrence after Endoscopic Clearance of Bile Duct Stones in Korea
| YONSEI MEDICAL JOURNAL |
2015 | Pathological Complete Remission of Pancreatic Cancer Following Neoadjuvant Chemoradiation Therapy; Not the End of Battles
| MEDICINE |
2015 | Efficacy of Adjuvant Chemotherapy and Prognostic Factors for Patients with Extrahepatic Bile Duct Cancer | CHEMOTHERAPY |